Save your place

Sign in to WhoBought

Please try again later.

ImmunityBio, Inc. (IBRX) institutional ownership

Latest close $7.76 May 19, 2026
Market cap$2.4B 52-week range SectorHealthcare
Funds holding · Q1 2026
361
reported IBRX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net bought $62M
273 buyers · 88 sellers

ImmunityBio, Inc. (IBRX) price and institutional activity

Dates

Q1 2026

$318M bought by 273 investors
D. E. Shaw & Co., Inc.$86MHrt Financial LP$27M +271 more
$256M sold by 88 investors
Jane Street Group, LLC-$93MAlphacore Capital LLC-$20M +86 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

ImmunityBio, Inc. (IBRX) institutional activity · 361

Investor Type Est. change Change Δ Own Date
Jane Street Group, LLC · Reduced −$93M
Change −13.5M Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −$93M −13.5M Q1 2026
D. E. Shaw & Co., Inc. · New +$86M
Change +12.6M Date Q1 2026
D. E. Shaw & Co., Inc. New· Q1 2026 +$86M +12.6M Q1 2026
Hrt Financial LP · New +$27M
Change +3.9M Date Q1 2026
Hrt Financial LP New· Q1 2026 +$27M +3.9M Q1 2026
Alphacore Capital LLC · Reduced −$20M
Change −3.0M Date Q1 2026
Alphacore Capital LLC Reduced· Q1 2026 −$20M −3.0M Q1 2026
Voloridge Investment Management, LLC · New +$20M
Change +2.9M Date Q1 2026
Voloridge Investment Management, LLC New· Q1 2026 +$20M +2.9M Q1 2026
Goldman Sachs Group Inc · Reduced −$20M
Change −2.9M Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −$20M −2.9M Q1 2026
Susquehanna International Group, LLP · Reduced −$17M
Change −2.5M Date Q1 2026
Susquehanna International Group, LLP Reduced· Q1 2026 −$17M −2.5M Q1 2026
Seb Asset Management AB · New +$17M
Change +2.4M Date Q1 2026
Seb Asset Management AB New· Q1 2026 +$17M +2.4M Q1 2026
Tang Capital Management LLC · Exited −$16M
Change −2.3M Δ Own −100.0% Date Q1 2026
Tang Capital Management LLC Exited· Q1 2026 −$16M −2.3M −100.0% Q1 2026
Squarepoint Ops LLC · Exited −$10M
Change −1.5M Δ Own −100.0% Date Q1 2026
Squarepoint Ops LLC Exited· Q1 2026 −$10M −1.5M −100.0% Q1 2026
Private Advisor Group, LLC · Added +$10M
Change +1.5M Date Q1 2026
Private Advisor Group, LLC Added· Q1 2026 +$10M +1.5M Q1 2026
Royal Bank of Canada · Added +$9.6M
Change +1.4M Date Q1 2026
Royal Bank of Canada Added· Q1 2026 +$9.6M +1.4M Q1 2026
Federated Hermes, Inc. · New +$9.5M
Change +1.4M Date Q1 2026
Federated Hermes, Inc. New· Q1 2026 +$9.5M +1.4M Q1 2026
Skandinaviska Enskilda Banken AB (publ) · Exited −$9.1M
Change −1.3M Δ Own −100.0% Date Q1 2026
Skandinaviska Enskilda Banken AB (publ) Exited· Q1 2026 −$9.1M −1.3M −100.0% Q1 2026
Millennium Management LLC · Added +$8.9M
Change +1.3M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +$8.9M +1.3M Q1 2026
Data through Q1 2026 · filed Jun 9, 2026
15 of 361

Famous investor activity in ImmunityBio, Inc. (IBRX)

ImmunityBio, Inc. (IBRX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Cohen Cheryl · Director Sell −$1.2M
Price $9.50 Qty −131K Owned 125K ΔOwn −51.1% Trade date Jul 2, 2026 Filed date Jul 6, 2026
Cohen Cheryl Director Sell $9.50 −131K −$1.2M 125K −51.1% Jul 2, 2026 Jul 6, 2026
Cohen Cheryl · Director 2 operations 0
Price $2.98 Owned 112K Trade date Jul 2, 2026 Filed date Jul 6, 2026
Cohen Cheryl Director 2 operations $2.98 0 112K Jul 2, 2026 Jul 6, 2026
Selecky Christobel · Director Sell −$1.4M
Price $9.02 Qty −159K Owned 0 ΔOwn −100.0% Trade date Jul 1, 2026 Filed date Jul 6, 2026
Selecky Christobel Director Sell $9.02 −159K −$1.4M 0 −100.0% Jul 1, 2026 Jul 6, 2026
Selecky Christobel · Director 4 operations 0
Price $2.98–$2.99 Owned 0 Trade date Jul 1, 2026 Filed date Jul 6, 2026
Selecky Christobel Director 4 operations $2.98–$2.99 0 0 Jul 1, 2026 Jul 6, 2026
Selecky Christobel · Director Sell −$9K
Price $9.00 Qty −1K Owned 0 ΔOwn −100.0% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Selecky Christobel Director Sell $9.00 −1K −$9K 0 −100.0% Jun 30, 2026 Jul 1, 2026
Selecky Christobel · Director 4 operations 0
Price $2.98–$2.99 Owned 124K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Selecky Christobel Director 4 operations $2.98–$2.99 0 124K Jun 30, 2026 Jul 1, 2026
Selecky Christobel · Director Sell −$862K
Price $9.01 Qty −96K Owned 0 ΔOwn −100.0% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Selecky Christobel Director Sell $9.01 −96K −$862K 0 −100.0% Jun 29, 2026 Jul 1, 2026
Selecky Christobel · Director 6 operations 0
Price $2.84–$2.99 Owned 133K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Selecky Christobel Director 6 operations $2.84–$2.99 0 133K Jun 29, 2026 Jul 1, 2026
Simon Barry J. · Director Sell −$197K
Price $7.88 Qty −25K Owned 2.8M ΔOwn −0.9% Trade date Jun 24, 2026 Filed date Jun 26, 2026
Simon Barry J. Director Sell $7.88 −25K −$197K 2.8M −0.9% Jun 24, 2026 Jun 26, 2026
Blaszyk Michael D. · Director Grant (A) 66K
Owned 66K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Blaszyk Michael D. Director Grant (A) 66K 66K Jun 9, 2026 Jun 10, 2026
Wendel Bruce · Director Grant (A) 66K
Owned 66K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Wendel Bruce Director Grant (A) 66K 66K Jun 9, 2026 Jun 10, 2026
Maxwell Linda · Director Grant (A) 66K
Owned 66K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Maxwell Linda Director Grant (A) 66K 66K Jun 9, 2026 Jun 10, 2026
Clark Wesley · Director Grant (A) 66K
Owned 66K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Clark Wesley Director Grant (A) 66K 66K Jun 9, 2026 Jun 10, 2026
Cohen Cheryl · Director Grant (A) 66K
Owned 66K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Cohen Cheryl Director Grant (A) 66K 66K Jun 9, 2026 Jun 10, 2026
Selecky Christobel · Director Grant (A) 66K
Owned 66K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Selecky Christobel Director Grant (A) 66K 66K Jun 9, 2026 Jun 10, 2026
15 of 50
15 of 50 Sign in to continue to older insider transactions.

ImmunityBio, Inc. (IBRX) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Cambridge Equities, LP 261.7M
% of shares outstanding 39.0% Filing date Jan 4, 2024
Cambridge Equities, LP 261.7M 39.0% Jan 4, 2024
1 of 1

ImmunityBio, Inc. (IBRX) ownership FAQ

Who owns IBRX?

361 reporting institutions disclosed IBRX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.